A recent comparison between mpMRI and PSMA PET/CT in primary index lesion, pelvic lymph node metastasis in staging intermediate-risk and high-risk prostate cancer patients has been studied by Szigeti et al.[7▪]. The gene discussed is FOLH1; the disease is prostate cancer.